No Data
No Data
Treace to Report Second Quarter 2024 Financial Results on August 6, 2024
Beyond The Numbers: 8 Analysts Discuss Treace Medical Concepts Stock
Truist Financial Maintains Treace Medical Concepts(TMCI.US) With Hold Rating, Announces Target Price $9
Treace Medical Concepts Price Target Raised to $9.00/Share From $7.00 by Truist Securities
Express News | Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $9
Truist Raises Price Target on Treace Medical Concepts to $9 From $7, Maintains Hold Rating
No Data